DV

Desikan Varadan

Active Director Director DIN 00958757
DIN 00958757 First appointment May 1996 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 1996
Shareholding value •••• Premium profile

About Desikan Varadan

Data last updated:

Desikan Varadan is a Director at Pharmachem Consultech India Private Limited (since 1996). The company operates in Pharma. Pharmachem Consultech India Private Limited reported revenue of ₹6.7 Lakh (FY 2025).

DIN 00958757
Primary Designation Director
Industry Pharma
First Appointment 16 May 1996
Oldest Company Age 30 yrs
Largest company Pharmachem Consultech India Private Limited · ₹6.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 May 19961996₹6.7 Lakh (FY 2025)Active

Board colleagues of Desikan Varadan

Directorship timeline

Open interactive timeline →
Pharmachem Consultech India Private Limited
Premium access

Shareholding and investment profile for Desikan Varadan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Desikan Varadan

Desikan Varadan currently holds 1 directorship: Pharmachem Consultech India Private Limited (Director, since 16 May 1996, revenue ₹6.7 Lakh (FY 2025)).

Desikan Varadan was first appointed on 16 May 1996 as Director at Pharmachem Consultech India Private Limited.

The current boards of Desikan Varadan's companies include Muthuswamy Venkatraju Iyer (Pharmachem Consultech India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available